Seoul, South Korea

Young Nam Park

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Seoul Pharm. Co., Ltd., Other. Active years: 1999.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Young Nam Park. Retrieved from https://idiyas.com/inventor/young-nam-park-5m90cgon

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:

goldMedal1 out of 1 
 
Seoul Pharm. Co., Ltd.
 patent
silverMedal1 out of 834,570 
Other
 patents
where one patent can have more than one assignee

Years Active: 1999

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Young Nam Park: Innovator in Hepatic Disease Treatment

Introduction

Young Nam Park is a notable inventor based in Seoul, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds aimed at treating hepatic diseases.

Latest Patents

Young Nam Park holds a patent for "Allylthiopyridazine derivatives and process for preparing the same." This invention relates to a novel allylthiopyridazine derivative that exhibits superior effects for the prevention and treatment of hepatic diseases induced by toxic substances. The compound also offers protection for human tissues from radiation. The patent is represented by a specific formula, which includes various substituents that enhance its therapeutic potential.

Career Highlights

Throughout his career, Young Nam Park has worked with Seoul Pharm. Co., Ltd., where he has contributed to the advancement of pharmaceutical innovations. His work has focused on creating effective treatments for serious health conditions, showcasing his commitment to improving patient outcomes.

Collaborations

Young Nam Park has collaborated with notable colleagues, including Soon Kyoung Kwon and Sang Geon Kim. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Young Nam Park's contributions to the field of pharmaceuticals, particularly through his patent on allylthiopyridazine derivatives, highlight his role as an innovator in the treatment of hepatic diseases. His work continues to impact the medical community positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…